DE2053733A1 - L Asparaginase m einem Gelmisch polymeren aus Acrylamid und N,N Methylen bis acrylamid enthaltendes Gemisch - Google Patents
L Asparaginase m einem Gelmisch polymeren aus Acrylamid und N,N Methylen bis acrylamid enthaltendes GemischInfo
- Publication number
- DE2053733A1 DE2053733A1 DE19702053733 DE2053733A DE2053733A1 DE 2053733 A1 DE2053733 A1 DE 2053733A1 DE 19702053733 DE19702053733 DE 19702053733 DE 2053733 A DE2053733 A DE 2053733A DE 2053733 A1 DE2053733 A1 DE 2053733A1
- Authority
- DE
- Germany
- Prior art keywords
- asparaginase
- acrylamide
- gel
- enzyme
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010024976 Asparaginase Proteins 0.000 title claims description 44
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 title claims description 39
- 239000000203 mixture Substances 0.000 title claims description 18
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 title claims description 13
- 229920000642 polymer Polymers 0.000 title claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 title claims description 8
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 title 1
- 229920001577 copolymer Polymers 0.000 claims description 2
- 239000000499 gel Substances 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- 229960003272 asparaginase Drugs 0.000 description 9
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 208000032839 leukemia Diseases 0.000 description 7
- 239000004971 Cross linker Substances 0.000 description 6
- 206010025323 Lymphomas Diseases 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- -1 Polyethylene, propylene Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UORWAUAKEOUUND-UHFFFAOYSA-N 5-phenylpenta-1,4-dienylbenzene Chemical compound C=1C=CC=CC=1C=CCC=CC1=CC=CC=C1 UORWAUAKEOUUND-UHFFFAOYSA-N 0.000 description 1
- 239000004160 Ammonium persulphate Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical class [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019395 ammonium persulphate Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 150000001508 asparagines Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- QYZLKGVUSQXAMU-UHFFFAOYSA-N penta-1,4-diene Chemical group C=CCC=C QYZLKGVUSQXAMU-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007717 redox polymerization reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01001—Asparaginase (3.5.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87367469A | 1969-11-03 | 1969-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2053733A1 true DE2053733A1 (de) | 1971-05-19 |
Family
ID=25362109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702053733 Pending DE2053733A1 (de) | 1969-11-03 | 1970-11-02 | L Asparaginase m einem Gelmisch polymeren aus Acrylamid und N,N Methylen bis acrylamid enthaltendes Gemisch |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU2163570A (enrdf_load_stackoverflow) |
| DE (1) | DE2053733A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2066944A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1288438A (enrdf_load_stackoverflow) |
| NL (1) | NL7015292A (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2114578B (en) * | 1979-11-06 | 1984-06-27 | Ki Med I | Polyacrylamide gel for medical and biological application and method of its preparation |
| FR2477033A1 (fr) * | 1980-02-28 | 1981-09-04 | Ki Med I | Gel polyacrylamidique pour emploi medical et biologique et procede de sa preparation |
| CN112704774B (zh) * | 2020-12-24 | 2023-01-10 | 苏州森康微球医疗科技有限公司 | 一种填装有固定化l-天冬酰胺酶的血液灌流器及其制备方法和应用 |
-
1970
- 1970-10-19 NL NL7015292A patent/NL7015292A/xx unknown
- 1970-10-27 FR FR7038715A patent/FR2066944A1/fr not_active Withdrawn
- 1970-10-28 AU AU21635/70A patent/AU2163570A/en not_active Expired
- 1970-11-02 DE DE19702053733 patent/DE2053733A1/de active Pending
- 1970-11-02 GB GB5203670A patent/GB1288438A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU2163570A (en) | 1972-05-04 |
| NL7015292A (enrdf_load_stackoverflow) | 1971-05-05 |
| FR2066944A1 (enrdf_load_stackoverflow) | 1971-08-13 |
| GB1288438A (enrdf_load_stackoverflow) | 1972-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3128100C2 (de) | Absorptionsmittel für Blut und seröse Körperflüssigkeiten | |
| DE2647420C2 (de) | Modifiziertes Polysaccarid und Verfahren zu seiner Herstellung | |
| DE69418969T2 (de) | Kontrolle von Wasserstrom aus unterirdischen Lagerstätten | |
| DE1908290C3 (de) | Acrylamid-mischpolymerisat | |
| DE2712043A1 (de) | Verfahren zur erhoehung der absorptionsrate von acrylamidpolymerisaten fuer wasser oder salzloesung und mittel zu seiner durchfuehrung | |
| DE2508346A1 (de) | Verfahren zur herstellung von wasserloeslichen, praktisch linearen polymerisaten mit hohem molekulargewicht und nach dem verfahren hergestelltes polymerisat | |
| DE2400819A1 (de) | Verfahren zur herstellung fester zubereitungen von schwerloeslichen arzneimittelwirkstoffen in feinster verteilung | |
| DE1795126A1 (de) | Verfahren zur Gewinnung von wasserloeslichen Acrylamidpolimerisaten | |
| EP0318989A1 (de) | Polymerisate mit hoher Aufnahmegeschwindigkeit für wässrige Flüssigkeiten | |
| DE3209224A1 (de) | Verfahren zur herstellung von unloeslichen, nur wenig quellbaren polymerisaten von basischen vinylheterocyclen und deren verwendung | |
| DE1720449A1 (de) | Verfahren zur Herstellung von gepfropften Mischpolymerisaten | |
| DE2803421A1 (de) | Hydrophile copolymere, sie enthaltende gele und deren verwendung | |
| DE3027929A1 (de) | Verfahren zur herstellung von polysaccharid-copolymerisaten aus traeger mit enzymatischer aktivitaet | |
| DE2059165A1 (de) | Streptokinase in chemischer Bindung an eine Kohlehydratverbindung | |
| DE2142742A1 (de) | Verfahren zur herstellung von alkalibzw. ammoniumpolyacrylaten | |
| DE1792732B2 (de) | Verwendung von chemisch behandelten cellulosehaltigem fasermaterial als bodenverbesserungsmittel | |
| DE2946642A1 (de) | Immobilisiertes enzym, verfahren zu seiner herstellung und zu seiner reinigung sowie dessen verwendung zur durchfuehrung einer enzymatischen reaktion | |
| DE2053733A1 (de) | L Asparaginase m einem Gelmisch polymeren aus Acrylamid und N,N Methylen bis acrylamid enthaltendes Gemisch | |
| DE3543942A1 (de) | Hydrogele mit roentgenkontrast, ihre herstellung und ihre verwendung | |
| DE2803009C2 (de) | Verwendung eines Copolymeren als Zusatzmittel bei der Sekundär- und Tertiärgewinnung von Erdöl | |
| DE1259572B (de) | Verfahren zur Erhoehung der Viskositaet von polymeren N-Vinyllactamen | |
| DE2124123A1 (de) | Polynucleotid und Verfahren zu deren Herstellung | |
| DE2648834A1 (de) | Neoschizophyllan und verfahren zur herstellung desselben | |
| DE964902C (de) | Verfahren zur Herstellung von wasserloeslichen Mischpolymerisaten aus Acrylsaeure- und Methacrylsaeureamid in waessriger Loesung | |
| DE1812694B2 (de) | Verfahren zur Herstellung färbbarer Polyolefine |